Skip to search formSkip to main contentSkip to account menu

calpain inhibitor

Known as: CANP-I, calcium-activated neutral protease inhibitor, calpain inhibitors 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Diabetes is associated with a number of co-morbidities including an increased risk of developing cardiovascular diseases. The… 
2016
2016
We previously reported that simvastatin, an inhibitor of HMG-CoA reductase, inhibits atherosclerosis in rats. The present study… 
2010
2010
The Rengen Grassland Experiment in Germany, established in 1941, consists of the following fertilizer treatments applied under a… 
2005
2005
In addition to promoting insulin secretion, an increase in cytosolic Ca(2+) triggered by glucose has been shown to be crucial for… 
2005
2005
Objective:Cardiopulmonary bypass in infants and children can result in cardiopulmonary dysfunction through ischemia and… 
Highly Cited
2000
Highly Cited
2000
Reports suggest a role of calpains in degradation of wild-type p53, which may regulate p53 induction of apoptosis. A calpain… 
Highly Cited
1999
Highly Cited
1999
Myocardial ischemia/reperfusion activates a calcium-dependent protease, calpain, in the ischemic myocytes. It is not known…